Dr Reddy'S Sorafenib Tablets, Usp, Are Available In 200 Mg Tablets In Bottle Count Sizes Of 120 And Are Used In The Treatment Of Liver, Kidney And Thyroid Cancer. Ney And Thyroid Cancer.Dr Reddy'S Laboratories On Tuesday Said It Has Launched Sorafenib Tablets, Used In The Treatment Of Various Cancers, In The Us Market After Getting Approval From The Us Food And Drug Administration (Usfda). "We Are Pleased To Launch This Important Generic Product, Illustrating Our Continued Commitment To Bring Affordable Generic Medicines To Market For Patients," Dr Reddy'S Laboratories Inc North America Generics Ceo Marc Kikuchi Said In A Statement. Dr Reddy'S Sorafenib Tablets, Usp, Are Available In 200 Mg Tablets In Bottle Count Sizes Of 120 And Are Used In The Treatment Of Liver, Kidney And Thyroid Cancer. The Company'S Product Is A Therapeutic Generic Equivalent Of Bayer Healthcare Pharmaceuticals Inc'S Nexavar Tablets.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!